×
0 0 0 0 0.0927374301675979 0.0927374301675979 0.0927374301675979 0.0927374301675979
Stock impact report

Cyclacel Pharmaceuticals Reports Second Quarter 2019 Financial Results

Cyclacel Pharmaceuticals, Inc (CYCC)  More Company Research Source: GlobeNewswire
Last cyclacel pharmaceuticals, inc earnings: 8/13 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.cyclacel.com/investor-relations
PDF - Conference Call Scheduled August 13, 2019 at 4:30 p.m. ET – BERKELEY HEIGHTS, N.J., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today reported financial results and business highlights for the second quarter 2019.  The Company's net loss applicable to common shareholders for the three months ended June 30, 2019 was $1.8 million.  As of June 30, 2019 cash and cash equivalents totaled $15.2 million. “We are excited to report new evidence of anticancer activity for CYC065. In part 2 of our Phase 1 study of CYC065 as a single agent, a patient with endometrial cancer with MCL1 amplification treated on the fourth dose level achieved tumor shrinkage. This patient was previously treated with liposomal doxorubicin, carboplatin, and multiple investigational therapies,” said Spiro Rombotis, President and Chief Executive O [Read more]
Impact snapshot Event time: CYCC
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
CYCC alerts
from News Quantified
Opt-in for
CYCC alerts

from News Quantified
Opt-in for
CYCC alerts

from News Quantified